Suppr超能文献

先天性因子 XIII 缺乏症中的纤维蛋白交联

Fibrin cross-linking in congenital factor XIII deficiency.

作者信息

Rodeghiero F, Barbui T

出版信息

J Clin Pathol. 1980 May;33(5):434-7. doi: 10.1136/jcp.33.5.434.

Abstract

Homozygous patients with factor XIII deficiency are devoid of immunologically identifiable A protein, the active enzymatic component. Quantitative studies of transamidase activity of the factor are available in only a few cases, and the fibrin cross-linking pattern is not well known. The present paper deals with the quantitative estimation of factor XIII transamidase activity (dansylcadaverine system), factor XIII molecular subunits, and the corresponding fibrin cross-linking pattern in seven homozygous patients with factor XIII deficiency. The results indicate that transamidase activity was present in all patients, and the range was 0.5-1.7%. The pattern of fibrin stabiisation showed an absence of cross-linking in two patients, the presence of gamma-gamma-dimers (traces) in four, and gamma-gamma-dimers plus incomplete alpha-polymers (traces) in one patient. In conclusion, the homozygous patients reported here were not completely devoid of functioning factor XIII.

摘要

患有因子 XIII 缺乏症的纯合子患者缺乏免疫学上可识别的 A 蛋白,即活性酶成分。仅在少数病例中对该因子的转酰胺酶活性进行了定量研究,并且纤维蛋白交联模式尚不清楚。本文探讨了 7 例患有因子 XIII 缺乏症的纯合子患者中因子 XIII 转酰胺酶活性(丹磺酰尸胺系统)、因子 XIII 分子亚基以及相应的纤维蛋白交联模式的定量评估。结果表明,所有患者均存在转酰胺酶活性,范围为 0.5 - 1.7%。纤维蛋白稳定模式显示,两名患者不存在交联,四名患者存在γ-γ-二聚体(微量),一名患者存在γ-γ-二聚体加不完全α-聚合物(微量)。总之,本文报道的纯合子患者并非完全缺乏有功能的因子 XIII。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c87e/1146106/6fcc1bc85fc3/jclinpath00465-0020-a.jpg

相似文献

1
Fibrin cross-linking in congenital factor XIII deficiency.
J Clin Pathol. 1980 May;33(5):434-7. doi: 10.1136/jcp.33.5.434.
3
Quantitation of factor XIII by SDS polyacrylamide gel electrophoresis.
Thromb Res. 1984 Sep 1;35(5):577-82. doi: 10.1016/0049-3848(84)90289-5.
4
A microtiter plate assay for factor XIII A-chain-fibrin interactions.
Anal Biochem. 1994 May 15;219(1):43-8. doi: 10.1006/abio.1994.1229.
5
Measurement of factor XIII activity in plasma.
Clin Chem Lab Med. 2012 Feb 23;50(7):1191-202. doi: 10.1515/cclm-2011-0730.
7
Incomplete fibrin formation and highly elevated Factor XIII activity in multiple myeloma.
Scand J Haematol. 1981 Oct;27(4):253-62. doi: 10.1111/j.1600-0609.1981.tb00481.x.
10
Assessment of Factor XIII.
Methods Mol Biol. 2017;1646:277-293. doi: 10.1007/978-1-4939-7196-1_22.

本文引用的文献

1
ACTIVATION OF THE FIBRIN STABILIZING FACTOR OF PLASMA BY THROMBIN.
Arch Biochem Biophys. 1964 Apr;105:58-67. doi: 10.1016/0003-9861(64)90235-8.
2
Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.
Anal Biochem. 1966 Apr;15(1):45-52. doi: 10.1016/0003-2697(66)90246-6.
4
The half-life of factor XIII in vivo.
Br J Haematol. 1970 Dec;19(6):685-90. doi: 10.1111/j.1365-2141.1970.tb07013.x.
5
Epsilon-(gamma glutamyl) lysine in fibrin: lack of crosslink formation in Factor 13 deficiency.
Proc Natl Acad Sci U S A. 1971 Apr;68(4):770-2. doi: 10.1073/pnas.68.4.770.
6
[Molecular structure of human fibrin stabilizing factors].
Blut. 1972 Oct;25(4):235-48. doi: 10.1007/BF01632188.
8
Cross-link in fibrin polymerized by factor 13: epsilon-(gamma-glutamyl)lysine.
Science. 1968 May 24;160(3830):892-3. doi: 10.1126/science.160.3830.892.
10
Comparative studies on tissue transglutaminase and factor XIII.
Ann N Y Acad Sci. 1972 Dec 8;202:240-55. doi: 10.1111/j.1749-6632.1972.tb16338.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验